Once-weekly alendronate: Two year subgroup efficacy analyses in postmenopausal women with osteoporosis.

被引：0
|
作者：
Bone, H
Felsenberg, D
Greenwald, M
Schnitzer, T
Kaur, A
Cudny, M
Peverly, C
Orloff, J
Santora, A
机构：
[1] Michigan Bone & Mineral Clin PC, Detroit, MI USA
[2] Free Univ Berlin Klinikum, Berlin, Germany
[3] Desert Med Advances, Palm Desert, CA USA
[4] Northwestern Univ, Chicago, IL 60611 USA
[5] Merck Res Labs, Rahway, NJ USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S526 / S526
页数：1
相关论文
共 50 条
  • [1] Once-weekly alendronate: Two-year subgroup efficacy analyses in postmenopausal women with osteoporosis
    Bone, H
    Felsenberg, D
    Greenwald, M
    Schnitzer, T
    Kaur, A
    Peverly, C
    Cudny, M
    Orloff, J
    Santora, A
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S30 - S30
  • [2] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Uebelhart, B
    Peverly, C
    Kaur, A
    Wu, M
    Orloff, J
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S527 - S527
  • [3] Once-weekly alendronate: Subgroup efficacy analyses.
    Bone, H
    Roux, C
    Schnitzer, T
    Smith, I
    Insogna, K
    Miller, P
    Santora, A
    Kaur, A
    Yates, J
    Orloff, J
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2001, 10 (04): : 404 - 404
  • [4] Once-weekly alendronate: Subgroup efficacy analyses.
    Bone, H
    Roux, C
    Schnitzer, T
    Smith, I
    Insogna, KL
    Miller, P
    Santora, A
    Kaur, A
    Yates, J
    Orloff, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S197 - S197
  • [5] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Uebelhart, B
    Foldes, J
    Peverly, C
    Santora, A
    Kaur, A
    Wu, M
    Orloff, J
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 25 - 25
  • [6] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Foldes, J
    Uebelhart, B
    Peverly, C
    Santora, A
    Kaur, A
    Wu, M
    Orloff, J
    BONE, 2001, 28 (05) : S94 - S94
  • [7] Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
    Greenspan, SL
    Bone, G
    Schnitzer, TJ
    Watts, NB
    Adami, S
    Foldes, AJ
    Roux, C
    Levine, MA
    Uebelhart, B
    Santora, AC
    Kaur, A
    Peverly, CA
    Orloff, JJ
    Rizzoli, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (11) : 1988 - 1996
  • [8] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis.
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Yates, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S64 - S64
  • [9] Alendronate 70 mg Once Weekly and alendronate 10 mg Once Daily preference study in postmenopausal women with osteoporosis.
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, M
    Wang, L
    Yates, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S404 - S404
  • [10] Efficacy of once a week risedronate in comparison with once-weekly alendronate therapy for postmenopausal osteoporosis: One-year data.
    Wimalawansa, SJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S404 - S404
12345